secwatch.observer — SEC 8-K summary
======================================

Issuer:     Monte Rosa Therapeutics, Inc. (GLUE)
CIK:        0001826457
Form:       8-K
Filed at:   2026-06-11T20:01:15+00:00
Accession:  0001193125-26-267465
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Monte Rosa stockholders elect three Class II directors, ratify Deloitte as auditor
--------------------------------------------------------------------------------

- Andrew Schiff, M.D., Chandra P. Leo, M.D., and Anthony Manning, Ph.D. elected as Class II directors for three-year terms ending 2029.
- Schiff received 71.4M votes for, 741K withheld; Manning received 57.0M for, 15.2M withheld.
- Ratification of Deloitte & Touche LLP as independent auditor for FY2026 passed with 75.2M for, 58K against, 50K abstain.
- No other matters were submitted to or voted on at the June 11, 2026 Annual Meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1826457/000119312526267465/0001193125-26-267465-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1826457/000119312526267465/glue-20260611.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-267465

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer